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Abstract
Background: Host susceptibility to P.falciparum is critical for understanding malaria in pregnancy,
its consequences for the mother and baby, and for improving malaria control in pregnant women.
Yet host genetic factors which could influence placental malaria risk are little studied and there are
no reports of the role of blood group polymorphisms on pregnancy outcomes in malaria endemic
areas.
This study analyses the association between ABO blood group phenotypes in relation to placental
malaria pathology.
Methods: A total of 198 mother/child pairs delivering in Banjul and the Kombo-St Mary District
(The Gambia) were analysed. ABO blood group was measured by agglutination. Placental malaria
parasites wee enumerated and the presence of malaria pigment noted. Birth anthropometry was
recorded and placental weight. Maternal and infant haemoglobin was measured.
Results:  89 (45%) subjects were primiparae and 110 (55%)multiparae. The ABO phenotype
distribution was 38(A), 52(B), 6(AB) and 102(O). Placental histo-pathology showed active placental
malaria in 74 (37%), past infection in 42 (21%) and no infection in 82 cases (41%). In primiparae
blood group O was associated with a higher risk of active infection (OR = 2.99; 95% CI = 1.24–
7.25), and a lower risk of past infection (OR = 0.31, 0.10–1.01, p < 0.05). In multiparae the O
phenotype was associated with reduced prevalence of active or past placental infection (OR = 0.45;
95% CI 0.21–0.98). The mean feto-placental weight ratio was significantly higher in multiparae with
group O women compared to non-O phenotypes (5.74 vs 5.36; p = 0.04). Among primiparae with
active placental infection, mean birth weight was higher in children of mothers with the O
phenotype (p = 0.04).
Conclusion: These results indicate that blood group O was significantly associated with increased
placental malaria infection in primiparae and reduced risk of infection in multiparae. This parity
related susceptibility was not present with other ABO phenotypes. Cell surface glycans, such as
ABO and related antigens have special relevance in reproductive biology and could modulate
specific cell interactions as those associated with the pathogenesis of placental malaria.
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Background
In malaria endemic areas, the increased risk of P. falci-
parum  infection during pregnancy, which is associated
with placental parasitaemia, imposes a heavy burden on
the health of mothers and newborns [1,2], contributing to
maternal anaemia, low birth weight, and infant mortality
especially among primiparae [3,4]. At present, available
preventive and therapeutic tools can only achieve a partial
reduction in the health hazards caused by placental
malaria [5,6]. In this context, a better knowledge of host
susceptibility to placental P.falciparum infection is central
for improving understanding of malaria in pregnancy, as
a basis for improved control.
There is increasing evidence that both the risk of acquiring
P. falciparum infection, and the risk of developing severe
complications are determined by host genetic factors [7].
The protective role of several erythrocytic variants, some
of them related to blood groups, is one of the best exam-
ples of this genetic modulation [8]. These include haemo-
globins S, C and E, α and β thalassaemias, Glucose-6-
phosphate dehydrogenase deficiency, Southern Asian
Ovalocytosis, and Glycophorins A, B and C variants, all of
which influence malaria pathogenesis [9].
ABO blood groups are carbohydrate histo-blood antigens
that are also expressed in many tissues and which have
important roles in modulating protein activities both in
infection and in some types of cancer [10]. These antigens
are formed by terminal glycosylation of glycoproteins and
glycolypid chains present on cell surfaces. Glycosylation
modulates all kinds of cell-to-cell interactions and this
may be relevant in malaria pathophysiology, where adhe-
sion has been increasingly implicated in disease severity.
Studies examining the effects of the ABO blood group
phenotype on malaria risk in non-pregnant subjects, have
shown inconsistent results [11-13]. Blood group A has
been reported as a risk factor for severe malaria [14], and
as a co-receptor for P.falciparum resetting [15], whereas
blood group O may offer some protection against severity
of disease [16].
No studies have been identified in the literature assessing
associations of blood group types with placental malaria,
despite the fact that placental parasites are unable to
rosette [17], in contrast to isolates from non-pregnant
subjects. Cell surface glycans have an essential role in
reproductive biology, and the adhesion and implantation
of the blastocyst is partly mediated by carbohydrates with
blood group specificity [18]. Each mammalian species has
its own glycotype at the feto-maternal interface, and this
variation depends on both evolution and the environ-
ment [19]. ABO histo-blood groups and related antigens
are expressed in the endometrium and are modulated by
the hormonal environment [20], but are not expressed in
the placenta and fetal endothelium where only other
related blood groups can be detected in the interstitial tro-
phoblast directly apposed to the maternal decidua [21]. In
contrast, examination of the glycan expression at the feto-
maternal interface using lectins, some with ABO determi-
nant specificity have shown binding with placental struc-
tures [22,23].
In this analysis we present the first report to describe the




Data from a group of 198 mother/child pairs were ana-
lysed from a cross-sectional study of placental malaria
undertaken in the Gambia. The original descriptive study
assessed serum Ig levels in mothers and newborns in rela-
tion to placental parasitaemia. The primary outcomes and
a detailed description of the methodology are outlined in
the original publication [24].
Mothers and their newborn babies were included in the
study from September 1967 to May 1968 in Banjul and
the Kombo-St Mary District (The Gambia). In this area
malaria is endemic with peak transmission during and
shortly after the rainy season which lasts from July to
October [25]. Mothers and babies were examined soon
after delivery at the Royal Victoria Hospital, Banjul, or in
one of the maternal and child welfare centres in the
Kombo-St Mary District. Basic demographic information
was recorded. The weight (g) and length (cm) of the baby
were measured by a physician within a few hours of birth.
Placentas were transported twice daily to the Medical
Research Council Laboratories where they were weighed
and examined for placental pathology. Placental blood
and maternal and neonatal peripheral venous blood were
collected, and blood films were prepared and stained by
standard methods. Parasitaemia was counted in the
peripheral blood against the number of white cells, and in
the placental blood by assuming that 1 parasite per 100
oil-immersion fields represented a density of 10 parasites/
mm3 blood. Maternal and infant haemoglobin was meas-
ured.
Data were entered on punch cards and for all births the
following data was available: maternal age, parity, haemo-
globin and peripherical parasitaemia; the babies gender,
weight, length and haemoglobin. The ABO and Rhesus
blood group phenotype of mother and baby were
recorded and the placental weight (g), parasite count and
presence of malaria pigment. All data was entered into a
SPSS data file.Malaria Journal 2006, 5:72 http://www.malariajournal.com/content/5/1/72
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Clinical definitions
Placental malaria definition was based on the pathologi-
cal classification of Bulmer et al [26], which comprises the
following groups: non-infected; acute infection (presence
of parasites without pigment); chronic infection (presence
of parasites and pigment); past infection (parasites not
present; pigment present). Acute and chronic placental
malaria were also grouped as 'active' infection.
Statistical analysis
Dichotomous variables were assessed with chi-square or
Fisher exact tests, with p values less than 0.05 considered
statistically significant. Odds ratios and 95% confidence
intervals were estimated. Differences between means were
assessed by ANOVA where data was normally distributed,
or the Mann-Whitney/Wilcoxon Test. Multiple linear
regression was used to analyse factors associated with
anthropometric outcomes. Factors included were those
significant at p = 0.1 in the univariate analysis. For anthro-
pometric variables the factors included where: maternal
blood group (O versus non O), parity, placental infection,
maternal haemoglobin, maternal peripheral parasitaemia
and maternal height.
Results
Eighty-eight of the 198 women were primiparae (45%)
who had a mean age of 17.8 years (SD ± 1.8). The mean
age of multiparae was 29.7 years (± 6.1). Placental malaria
was present in 116 cases (59%), with active placental
malaria infection in 74 (37.4%), of which 26 (13.1%)
were acute and 48 (24.2%) chronic infections. Past infec-
tion was detected in 42 women (21.2%). In the remaining
82 cases (41%) there was no evidence for current or previ-
ous placental malaria. Among primiparae, 56 (63%) had
evidence of placental infection of which 41 (47%) were
active, 12 (14%) acute and 29 (33%) chronic infections.
Among multiparae 60 (55%) had evidence of placental
infection with 33 (30%) active, 14 (13%) acute and 19
(17%) chronic (Table 1). Primiparae were at increased
risk for active placental malaria (OR 1.99, 95% CI 1.11 –
3.57), and more specifically the chronic infection (OR
2.32, 95% CI 1.19–4.5).
The male/female ratio was significantly increased in active
placental malaria OR = 1.87 (95%CI 1.04–3.39), p = 0.04
and decreased in past infection OR = 0.45 (95%CI 0.22–
0.90), p = 0.02.
There was no significant association between O or non-O
blood groups and placental infection when parity was not
considered, except for past placental malaria which was
less prevalent in women with blood group O (OR 0.39,
95% CI 0.18–0.84, p < 0.01). In primiparae blood group
O was associated with more active placental malaria (OR
2.99, 95% CI 1.24–7.25, p < 0.05) and less past placental
malaria (OR = 0.31, 0.10–1.01, p < 0.05) than in non-O
women. In multiparae, blood group O was significantly
associated with non-infected placentae (OR 2.22, 95% CI
1.03–4.78, p < 0.05) compared to non-O women (Table
1). The effect of parity on the risk of placental infection
was significant for the O blood group sub-population
with lower risk of active infection in multigravidae (OR
0.27, 95% CI 0.12–0.62, p < 0.01) compared with primi-
parae of the same blood group. For non-O blood groups,
there were no significant parity differences in risk of active
(OR 1.06, 95%CI 0.44–2.59, p = 0.9) or past placental
infection (OR 0.79, 95%CI 0.32–1.98, p = 0.6). The effect
of parity on the risk of active placental infection was sig-
nificantly different for the two sub-populations O and
non-O, (Chi-square 4.98, p = 0.03).
Table 2 summarises birth outcomes by blood group phe-
notype. In primiparae, with active placental infection,
mean birth weight was significantly higher in babies born
to blood group O mothers (2893 g versus 2639 g, p =
0.04).
Maternal haemoglobin (Hb) concentration was higher in
O type mothers with active placental malaria (11.65 g/dl,
versus 10.53 g/dl) although this difference was not statis-
tically significant (p = 0.48). There were no significant dif-
ferences in mean infant haemoglobin, infant length,
placental weight, ponderal index or placental parasitae-
mia prevalence by blood group category (table 2).
Mean feto-placental weight ratio was increased in blood
group O compared to non-O (p = 0.06) and was signifi-
cant in multiparae (5.74 versus 5.36; p = 0.04), (Figure 1).
Blood group phenotype (O versus non-O) was an inde-
pendent predictor of the higher feto-placental weight
ratio, (linear regression coefficient = 0.26, p = 0.04). The
other malaria parameters, did not show any significant
associations with blood groups on multivariate analysis.
The Rhesus blood group type showed no significant asso-
ciations in relation to placental malaria categories or birth
outcomes.
Discussion
Blood group O was associated with an increased preva-
lence of active placental infection in primiparae and with
a reduced risk of placental malaria in multiparae. Placen-
tal parasitaemia occurs at least twice as frequently in prim-
iparae but only among blood group O women. This effect
of parity, that is one of the cardinal features of placental
malaria, was not observed in non-O phenotypes for any of
the placental malaria histological types.
In multiparae and specifically in mothers with past or
non-infected placentae blood group O was also associatedMalaria Journal 2006, 5:72 http://www.malariajournal.com/content/5/1/72
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with higher mean feto-placental weight ratios compared
to non-O individuals. These differences associated with
multiparity can be interpreted to represent a parity-spe-
cific association of the blood group O phenotype with the
protective malarial immunity which occurs in multigravi-
dae [3]. Mean birth weight was also significantly increased
in babies of primiparae with the O phenotype, suggesting
that despite the greater susceptibility of primigravidae to
placental malaria, the O phenotype may be partially pro-
tective leading to improved birth anthropometry.
In non-pregnant individuals blood group O has been
associated with reduced risk of severe clinical malaria
compared to patients with groups A or B [14,16], but this
occurred without clear evidence for reduced prevalence of
parasitaemia associated with blood group O [12,13]. This
would suggest that the ABO phenotypes may be associ-
ated more with modification of disease severity than with
infection risk. None of these women had HIV infection as
the study was conducted in the early 1970s before this
human immunodeficiency virus was described or trans-
Table 2: Mean birth outcomes by parity and maternal blood group phenotype




























Active (†) O group 29 11.65 (1.6) 18.5 (3.1) 2893 
(362)*
49.0 (1.8) 559 (123) 2.51 
(0.24)
5.26 (0.9) 2.74 
(1.36)
non-O 12 10.53 (3.1) 19.4 (3.0) 2639 
(323)*
47.9 (1.9) 513 (115) 2.45 
(0.15)
5.3 (0.9) 3.18 
(1.48)
Past or no 
infection
O group 21 12.0 (1.3) 18.2 (2.2) 2941 
(455)
48.6 (1.6) 544 (135) 2.59 
(0.22)
5.62 (1.22)
non-O 26 11.8 (2.3) 18.2 (2.0) 2894 
(430)
48.9 (1.8) 559 (100) 2.5 (0.21) 5.28 (0.9)
Multipar
ae
Active O group 14 11.9 (1.4) 18.5 (2.0) 3151 
(705)
49.7 (2.4) 578 (124) 2.55 
(0.26)
5.53 (1.15) 2.28 
(1.19)
non-O 19 12.3 (1.5) 18.7 (2.5) 3366 
(312)
50.0 (1.8) 652 (169) 2.68 
(0.20)
5.39 (1.1) 2.53 
(1.18)
Past or no 
infection
O group 38 12.2 (1.5) 18.6 (2.1) 3315 
(537)




non-O 39 11.8 (1.5) 18.7 (2.3) 3093 
(521)




†Active: acute and chronic infection
‡Ponderal Index = weight/length3
* p value = 0.04
§p value = 0.02
Table 1: ABO phenotype by placental malaria category and parity group
Parity Placental malaria Phenotype N (%) OR 95% CI O/non O
Type No A B AB O
Primiparae Active 41 6 (37) 6 (30) 0 (0) 29 (58) 2.99, 1.24–7.25
Past 15 4 (25) 4 (20) 2 (100) 5 (10) 0.3, 0.1–1.0
None 33 6 (37) 10 (50) 0 (0) 16 (32) 0.65, 0.27–1.55
Total 88 16 20 2 50
Multiparae Active 33 6 (27) 11 (29) 2 (50) 14 (27) 0.75, 0.33–1.7
Past 27 8 (36) 10 (31) 0 (0) 9 (17) 0.47, 0.19–1.15
None 50 8 (36) 11 (34) 2 (50) 29 (56) 2.22, 1.03–4.78
Total 110 22 32 4 52
Brackets: percentageMalaria Journal 2006, 5:72 http://www.malariajournal.com/content/5/1/72
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mitted. This indicates that these results are not con-
founded by an immunosuppressive effect of HIV virus
infection.
This is the first time an association of birth outcomes with
placental malaria and maternal ABO phenotype has been
reported. This raises the question of the possible mecha-
nisms underlying the association. A central mechanism in
the pathogenesis of placental malaria relates to the
cytoadherence of infected red cells to the syncytiotro-
phoblast which is in contact with maternal blood. The
parity related susceptibility to placental malaria is partly
dependent on the selection of P.falciparum isolates which
bind to trophoblast via chondroitin sulphate A (CSA) [27]
and hyaluronic acid [28]. Infected red cells can also bind
to the proteoglycan thrombomodulin, present on
endothelial cells and placental syncytiotrophoblast, via
CSA side chains [29]. Soluble adhesion molecules and
endothelial markers (including won Willebrand factor
and E-selectin) are associated with ABO phenotypes, espe-
cially thrombomodulin which is lower in group O and A
than B plasma (P < 0.001) [30].
Duffy binding-like domains (DBL) of the P. falciparum
erythrocyte membrane protein 1 (PfEMP1) mediate bind-
ing to several independent host receptors [31] and in pla-
cental isolates it is the DBL-γ3 domain which binds to
chondroitin sulfate A (CSA) in syncytiotrophoblast
[32,33]. However, there is no published evidence of an
association between DBL-γ3 and the ABO phenotype,
although it has been shown that the DBL1α domain has
an affinity for the blood group A antigen [34].
The interaction between the ABO histo-blood group and
placental malaria could relate to generic mechanisms
affecting P.falciparum infection. For example the differen-
tial affinity of each phenotype for A.gambiae [35], or anti-
gen sharing between ABO phenotypes and P.falciparum
leading to changes in immune response [36], or an asso-
ciation with Glycophorin A (GPA) which is an important
determinant for P.falciparum  entry into the red cell
through GPA sialic acid, as ABH antigens have been
described in the O-glycans of glycophorin A [37]. In addi-
tion ABO phenotypes differ in sialic acid content and
composition, with group O showing the highest mem-
brane content, but a lower percentage of sialoglycopro-
teins [38].
It is well known that host genetic factors modulate the risk
and severity of infection. In most cases these are genetic
variants with subtle effects on the regulation or function
of specific mediators which are often difficult to demon-
strate in epidemiological studies [39]. As there is increas-
ing evidence that cell adhesion plays a decisive role in
placental malaria pathophysiology, it is clear that cell sur-
face glycans, such as the ABO and related antigens which
have special relevance in reproductive biology, could
modulate some of those specific cell interactions. Their
association with placental malaria risk, birth outcomes
and parity related susceptibility, provides a new insight
into these interactions and into the role of glycosylation
and host-specific genetic factors in placental malaria.
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